Keywords: cor, new, gpiia/iiib, inhibitor, therapeutics, once-daily, oral

COR's new gpIIa/IIIb inhibitor

Article | 11 November 1999

COR Therapeutics' new once-daily oral gpIIa/IIIb inhibitor cromafibanachieved predictable and consistent levels of platelet aggregation inhibition at each dose ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Nystatin

Go to drug listing